Harold E. Varmus

Last updated
Constance Louise Casey
​
​
(m. 1969)​
Harold E. Varmus
National Cancer Institute director Harold E. Varmus (3) (cropped).jpg
Varmus in 2009
14th Director of the National Cancer Institute
In office
2010–2015
Children2
Alma mater
Known for
Awards
Scientific career
FieldsCancer biology
Institutions
Doctoral students Kirsten Bibbins-Domingo [1]
Tyler Jacks [2]

Harold Eliot Varmus (born December 18, 1939) is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

Contents

He was a co-recipient (along with J. Michael Bishop) of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes. He was also the director of the National Institutes of Health from 1993 to 1999 and the 14th Director of the National Cancer Institute from 2010 to 2015, a post to which he was appointed by President Barack Obama. [3] [4]

Early life and education

Varmus was born on December 18, 1939, to Beatrice, a social service worker, and Frank Varmus, a physician, Jewish parents of Eastern European descent, in Oceanside, New York. [5] [6] [7] In 1957, he graduated from Freeport High School in Freeport, New York, and enrolled at Amherst College, intending to follow in his father's footsteps as a medical doctor, but eventually graduating with a B.A. in English literature. [5] He went on to earn an M.A. in English at Harvard University in 1962, before changing his mind once again and applying to medical schools. [7] [8] He was twice rejected from Harvard Medical School. That same year, he entered the Columbia University College of Physicians and Surgeons and later worked at a missionary hospital in Bareilly, India, and the Columbia Presbyterian Medical Center. [5] As an alternative to serving militarily in the Vietnam War, Varmus joined the Public Health Service at the National Institutes of Health in 1968. [8] Working under Ira Pastan, he researched the regulation of bacterial gene expression by cyclic AMP. In 1970, he began postdoctoral research in Bishop's lab at University of California, San Francisco. [5] [7]

Scientific career and research accomplishments

To fulfill his national service obligations during the Vietnam War, Varmus became a member of the commissioned corps of the Public Health Service, working as a Clinical Associate in the laboratory of Ira Pastan at the National Institutes of Health from 1968 to 1970. During this first period of laboratory research, he and Pastan and their colleagues described aspects of the mechanism by which the lac operon of E. coli is regulated transcriptionally by cyclic AMP. [9] In 1970, he and his wife, Constance Casey, moved to San Francisco, where he began post-doctoral studies with Michael Bishop at University of California, San Francisco under a fellowship from the California Division of the American Cancer Society. [10] Appointed as an assistant professor in the UCSF Department of Microbiology and Immunology in 1972, he was promoted to professor in 1979 and became an American Cancer Society Research Professor in 1984.

During the course of his years at UCSF (1970 to 1993), Varmus's scientific work was focused principally on the mechanisms by which retroviruses replicate, cause cancers in animals, and produce cancer-like changes in cultured cells. Much of this work was conducted jointly with Michael Bishop in a notably long scientific partnership. Their best-known accomplishment [11] was the identification of a cellular gene (c-Src) that gave rise to the v-Src oncogene of Rous sarcoma virus, a cancer-causing virus first isolated from a chicken sarcoma by Peyton Rous in 1910. Their discovery triggered the identification of many other cellular proto-oncogenes—progenitors of viral oncogenes and targets for mutations that drive human cancers. Much of this work and its consequences are described in his Nobel lecture [12] and Bishop's, [13] in Varmus's book The Art and Politics of Science, [10] and in numerous histories of cancer research. [14] [15]

Other significant components of Varmus's scientific work over the past four and a half decades include descriptions of the mechanisms by which retroviral DNA is synthesized and integrated into chromosomes; [16] [17] discovery of the Proto-oncogene Wnt-1 with Roel Nusse; [18] [19] elucidation of aspects of the replication cycle of hepatitis B virus (with Donald Ganem [20] ); discovery of ribosomal frameshifting to make retroviral proteins (with Tyler Jacks [21] ); isolation of a cellular receptor for avian retroviruses (with John Young and Paul Bates [22] ); characterization of mutations of the epidermal growth factor receptor gene in human lung cancers, including a common mutation that confers drug resistance (with William Pao [23] ); and generation of numerous mouse models of human cancer. Notably, Varmus continued to conduct or direct laboratory work throughout his service in leadership positions at the NIH, MSKCC, and NCI.

Politics and government service

In the early 1990s, following the award of their Nobel Prize, Varmus and Bishop became active in the politics of science, working principally with UCSF colleagues Bruce Alberts and Marc Kirschner, and with the Joint Steering Committee (later renamed the Coalition for the Life Sciences). [24] He also co-chaired Scientists and Engineers for Clinton-Gore during the 1992 presidential campaign.

National Institutes of Health directorship

Varmus in 2009 National Cancer Institute director Harold E. Varmus (2).jpg
Varmus in 2009

After the resignation of NIH Director Bernadine Healy in April, 1993, Varmus was nominated for the post by President William J. Clinton in July, and confirmed by the Senate in November. As the NIH director, Varmus was credited with helping to nearly double the research agency's budget; but his tenure was also noted for appointments of outstanding scientists to serve as Institute Directors; for excellent relationships with members of Congress and the Administration; for leadership on clinical and AIDS research; for policy statements about stem cell research, cloning of organisms, gene therapy, and patenting; for promoting global health research, especially on malaria; and for construction of new facilities, including a new Clinical Center and a Vaccine Research Center at the NIH. [25]

Between directorships

Varmus supported the presidential candidacies of Al Gore (2000) and John Kerry (2004). During the George W. Bush presidency, he gave lectures critical of the Administration's science policies. [26] But he has also written a laudatory account of PEPFAR (the President's Emergency Plan For AIDS Relief), Bush's initiative to combat AIDS globally. [27]

Varmus declared his support for Barack Obama's quest for the presidency early in 2008 [28] and chaired the campaign's Science and Technology Committee. Following Obama's election, he was named by the president-elect as one of three co-chairs of PCAST (the President's Council of Advisors on Science and Technology). [29] He resigned from that post to assume the directorship of the National Cancer Institute (NCI) on July 12, 2010, after being named to the post by President Obama. [30]

National Cancer Institute directorship

On May 17, 2010, the White House announced that Varmus would become the 14th Director of the NCI, making him the first person to have served as director of an individual NIH Institute after being director of the entire NIH. In this capacity, despite diminishing budgets at all the Institutes including NCI, he started new administrative centers for cancer genomics and global health; initiated novel grant programs for "outstanding investigators," for "staff scientists," and for addressing "Provocative Questions." [31] [32] He also renamed the Frederick National Laboratory for Cancer Research and started an initiative there to study RAS oncogenes. [33]

On March 4, 2015, Varmus submitted his resignation to the president, effective March 31, 2015, announcing his intention to return to New York City as the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and as a senior associate at the New York Genome Center. [34] [35] Deputy NCI Director Douglas Lowy became acting director of the NCI on April 1, 2015.

During his tenure as NCI Director, Varmus took the unusual step of co-authoring with three non-governmental colleagues a critique of several practices prevalent in the biomedical research community. [36] That essay has been the starting point for several subsequent efforts to reduce the hypercompetitive atmosphere in biomedical research. [37]

Presidency of Memorial Sloan Kettering Cancer Center

Varmus in 2000 Dr. Harold Varmus Director of the National Institutes of Health from 1993 until 1999 (14172851687).jpg
Varmus in 2000

After leaving the NIH Directorship at the end of 1999, Varmus became the president and CEO of Memorial Sloan-Kettering Cancer Center in New York City on January 1, 2000. During his ten and a half years at MSKCC, he was best known for enlarging the basic and translational research faculty; building a major new laboratory facility, the Mortimer E. Zuckerman Research Center; starting a new graduate school for cancer biology (the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences); overseeing renovation and construction of many clinical facilities; and leading a major capital campaign. [38] [39] He also continued to run an active laboratory and to teach as a Member of the Sloan-Kettering Institute. On January 12, 2010, MSKCC reported that Varmus had asked the MSKCC Boards of Overseers and Managers "to begin a search for his successor." He left MSKCC on June 30, 2010, shortly before assuming the NCI directorship.

Publication practices in science

Near the end of his tenure as NIH director, Varmus became a champion of ways to more effectively use the Internet to enhance access to scientific papers. [40] [41] The first practical outcome was the establishment, with David Lipman of the National Center for Biotechnology Information at NIH, of PubMed Central, a public digital library of full-length scientific reports; [42] in 2007, Congress directed NIH to ensure that all reports of work supported by the NIH appear in PubMed Central within a year after publication. [43] Varmus and two colleagues, Patrick Brown at Stanford and Michael Eisen at UC Berkeley, were co-founders and leaders of the board of directors of the Public Library of Science (PLOS), a not-for-profit publisher of a suite of open access journals in the biomedical sciences. [44]

Advisory roles

Varmus has been a frequent advisor to the US government, foundations, academic institutions and industry. Currently, he serves as a member of the Secretary of Energy's advisory board, the Global Health Advisory Board at the Bill and Melinda Gates Foundation, the board of directors of the International Biomedical Research Alliance, [45] the Lasker Foundation Prize Jury, and the Scientific Advisory Board of the Broad Institute at Harvard and MIT, and he chairs advisory groups for the Faculty of 1000 and the Global Alliance for Genomics and Health. In the past, he was chairman of the Grand Challenges in Global Health at the Gates Foundation, [46] a member of the World Health Organization's Commission on Macroeconomics and Health, [47] and an advisor to Merck & Co., Chiron Corporation, Gilead, and Onyx Pharmaceuticals. He has been chair of the World Health Organization's Science Council since its founding in 2021 [48]

Varmus has criticized the high cost of many modern cancer drugs, which create barriers to treatment. He advocates for the genetic testing of cancers as a routine reimbursed procedure, and for wider use of the information that genetic testing of cancer can provide. He argues that widespread use of panel tests and exome analyses to identify cancer-causing mutations would be simpler and cheaper than full genome analysis. He has argued for the coverage of such services under Medicare and Medicaid on the grounds of Coverage with Evidence Development, since the data could be used to better evaluate test and treatments. He supports the creation of a database of information that can be correlated with clinical outcomes for use by all oncologists. He is hopeful that researchers will soon use new technologies to move beyond the study of primary tumors, where they have had considerable success, and explore how cancer initiates and the development of metastasic cancers. [10]

Awards and honors

Personal life

Varmus has been married since 1969 to Constance Louise Casey, a journalist and science writer. They live on Manhattan's Upper West Side and have two sons: Jacob, a jazz trumpet player and composer who lives in Queens, and Christopher, a social worker who lives in Brooklyn. Varmus and Jacob have performed a series of lecture-concerts entitled "Genes and Jazz" at the Guggenheim [56] and Smithsonian Museums, the Boston Museum of Science, the John F. Kennedy Center for the Performing Arts and the South Asian Summer Festival in Vancouver.

See also

Related Research Articles

<span class="mw-page-title-main">Oncogene</span> Gene that has the potential to cause cancer

An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.

<span class="mw-page-title-main">University of California, San Francisco</span> Public university in California, US

The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

<span class="mw-page-title-main">Stanley B. Prusiner</span> American neurologist and biochemist

Stanley Ben Prusiner is an American neurologist and biochemist. He is the director of the Institute for Neurodegenerative Diseases at University of California, San Francisco (UCSF). Prusiner discovered prions, a class of infectious self-reproducing pathogens primarily or solely composed of protein, considered by many as a heretical idea when first proposed. He received the Albert Lasker Award for Basic Medical Research in 1994 and the Nobel Prize in Physiology or Medicine in 1997 for prion research developed by him and his team of experts beginning in the early 1970s.

The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.

<span class="mw-page-title-main">J. Michael Bishop</span> American immunologist and microbiologist

John Michael Bishop is an American immunologist and microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine with Harold E. Varmus. He serves as an active faculty member at the University of California, San Francisco (UCSF), where he also served as chancellor from 1998 to 2009.

<span class="mw-page-title-main">Memorial Sloan Kettering Cancer Center</span> Treatment and research hospital in New York City

Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.

<span class="mw-page-title-main">Wistar Institute</span> American biomedical research institute

The Wistar Institute is an independent, nonprofit research institution in biomedical science with special focuses in oncology, immunology, infectious disease and vaccine research. Located on Spruce Street in Philadelphia’s University City neighborhood, Wistar was founded in 1892 as a nonprofit institution to focus on biomedical research and training.

<span class="mw-page-title-main">Harvey J. Alter</span> American medical researcher

Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.

<span class="mw-page-title-main">Francis Peyton Rous</span> American scientist (1879–1970)

Francis Peyton Rous was an American pathologist at the Rockefeller University known for his works in oncoviruses, blood transfusion and physiology of digestion. A medical graduate from the Johns Hopkins University, he was discouraged to become a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan, he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career.

v-Src is a gene found in Rous sarcoma virus (RSV) that encodes a tyrosine kinase that causes a type of cancer in chickens.

The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.

<span class="mw-page-title-main">Proto-oncogene tyrosine-protein kinase Src</span> Mammalian protein found in Homo sapiens

Proto-oncogene tyrosine-protein kinase Src, also known as proto-oncogene c-Src, or simply c-Src, is a non-receptor tyrosine kinase protein that in humans is encoded by the SRC gene. It belongs to a family of Src family kinases and is similar to the v-Src gene of Rous sarcoma virus. It includes an SH2 domain, an SH3 domain and a tyrosine kinase domain. Two transcript variants encoding the same protein have been found for this gene.

Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

The UCSF School of Medicine is the medical school of the University of California, San Francisco and is located at the base of Mount Sutro on the Parnassus Heights campus in San Francisco, California. Founded in 1864 by Hugh Toland, it is the oldest medical school in California and in the western United States. U.S. News & World Report ranked the school third in research training and second in primary care training; it is the only medical school in the nation to rank among the top three in both categories. Six members of the UCSF faculty have received the Nobel Prize in Physiology or Medicine and five have received the National Medal of Science.

<span class="mw-page-title-main">Maurice Green (virologist)</span> American virologist

Maurice Green was an American virologist. He was regarded as a pioneer in the study of animal viruses, in particular their role in cancer. Green founded the Institute of Molecular Virology at St. Louis University School of Medicine in the late 1950s, and later served as its chairman.

<span class="mw-page-title-main">Douglas R. Lowy</span>

Douglas R. Lowy is the current Principal Deputy Director of the U.S. National Cancer Institute (NCI) and Chief of the Laboratory of Cellular Oncology within the Center for Cancer Research at NCI. Lowy served as Acting Director of NCI between April 2015 and October 2017 following the resignation of Harold E. Varmus, M.D., and again between April and November 2019, while Director Norman Sharpless served as the Acting Commissioner of the U.S. Food and Drug Administration. He resumed the role of Acting Director on May 1, 2022, when Sharpless stepped down until October 3, 2022 when Monica Bertagnolli was appointed Director. He resumed the role again in November 2023 after Bertagnolli resigned to serve as director of the National Institutes of Health.

<span class="mw-page-title-main">Frederick National Laboratory for Cancer Research</span>

The Frederick National Laboratory for Cancer Research (FNLCR) is one of the 18 United States National Laboratories and the only U.S. National Laboratory exclusively dedicated to biomedical research. The Frederick National Laboratory is sponsored by NIH/National Cancer Institute (NCI) as a Federally Funded Research and Development Centers, and its day-to-day operation is managed by the private contractor Leidos Biomedical Research for the NCI. The institution was originally established under the name NCI-Frederick Cancer Research Center in 1972 as a component of U.S. President Richard Nixon's War on Cancer initiative. In 2012, the institution received a National Laboratory designation and assumed its current name, becoming the only U.S. national laboratory dedicated entirely to biomedical research. The campus located within Fort Detrick U.S. Army Installation in Frederick, Maryland, also houses National Cancer Institute laboratories and administrative organizations, and is colloquially referred to as NCI-Frederick.

<span class="mw-page-title-main">Electron Kebebew</span> American surgeon and researcher (born 1968)

Electron Kebebew is an American surgeon, educator and scientist. Kebebew is currently the Harry A. Oberhelman Jr. and Mark L. Welton Professor and Chief of General Surgery at Stanford University.

The 2020 Nobel Prize in Physiology or Medicine was awarded to the American virologists Harvey J. Alter, Michael Houghton and Charles M. Rice "for the discovery of Hepatitis C virus." During the award ceremony on December 10, 2020, Prof. Gunilla Karlsson-Hedestam said:

"The discovery of the Hepatitis C virus by this year’s Laureates laid the foundation for our current understanding about how the virus survives in its niche during the long chronic phase of the infection, and how liver disease develops. And importantly, it led to the development of highly effective anti-viral medicines that now cure the infection in almost all treated persons."

References

  1. ↑ "A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief". YouTube. JAMA Network. July 2022. (conversation with Harold Varmus)
  2. ↑ "Tyler Jacks". The Jacks Lab, Koch Institute for Integrative Research Cancer Research at MIT.
  3. ↑ "President Obama to Appoint Harold Varmus, M.D." National Cancer Institute. Archived from the original on May 27, 2010.
  4. ↑ "NIH Directors". 2015-02-11.
  5. 1 2 3 4 Les Prix Nobel. The Nobel Prizes 1989, Editor Tore Frängsmyr, Nobel Foundation, Stockholm, 1990.
  6. ↑ "Biography". National Cancer Institute. Archived from the original on January 4, 2014.
  7. 1 2 3 "Biographical Overview-Harold Varmus". NIH. 12 March 2019. Retrieved August 12, 2023.
  8. 1 2 Jamie Shreeve. "Free Radical". Wired Magazine. June 2006. Issue 14.06.
  9. ↑ Varmus, H.E.; Perlman, R.L.; Pastan, I. (1970). "Regulation of lac messenger ribonucleic acid synthesis by cyclic adenosine 3'-5' monophosphate and glucose". J. Biol. Chem. 245 (9): 2259–67. doi: 10.1016/S0021-9258(18)63147-3 . PMID   4315149.
  10. 1 2 3 Beil, Laura (November 17, 2017). "From academics to access, Harold Varmus reflects on the achievements and challenges in cancer research". Knowable Magazine. doi: 10.1146/knowable-112017-160500 .
  11. ↑ Stehelin, D.; Varmus, H. E.; Bishop, J. M.; Vogt, P. K. (1976-03-11). "DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA". Nature. 260 (5547): 170–173. Bibcode:1976Natur.260..170S. doi:10.1038/260170a0. PMID   176594. S2CID   4178400.
  12. ↑ "Nobel Lecture by Harold E. Varmus – Media Player at Nobelprize.org". www.nobelprize.org. Retrieved 2016-03-09.
  13. ↑ "Nobel Lecture by J. Michael Bishop – Media Player at Nobelprize.org". www.nobelprize.org. Retrieved 2016-03-09.
  14. ↑ Mukherjee, S. (2010). The Emperor of All Maladies: A Biography of Cancer. New York: Scribner. pp. 360–380.
  15. ↑ Varmus, Harold (2017-03-06). "How Tumor Virology Evolved into Cancer Biology and Transformed Oncology". Annual Review of Cancer Biology. 1 (1): 1–18. doi: 10.1146/annurev-cancerbio-050216-034315 .
  16. ↑ Varmus, H. (1988-06-10). "Retroviruses". Science. 240 (4858): 1427–1435. Bibcode:1988Sci...240.1427V. doi:10.1126/science.3287617. ISSN   0036-8075. PMID   3287617.
  17. ↑ Brown, P. O.; Bowerman, B.; Varmus, H. E.; Bishop, J. M. (1987-05-08). "Correct integration of retroviral DNA in vitro". Cell. 49 (3): 347–356. doi:10.1016/0092-8674(87)90287-x. ISSN   0092-8674. PMID   3032450. S2CID   35523639.
  18. ↑ Nusse, R.; Varmus, H. E. (1982-11-01). "Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome". Cell. 31 (1): 99–109. doi:10.1016/0092-8674(82)90409-3. ISSN   0092-8674. PMID   6297757. S2CID   46024617.
  19. ↑ Nusse, Roel; Varmus, Harold (2012-06-13). "Three decades of Wnts: a personal perspective on how a scientific field developed". The EMBO Journal. 31 (12): 2670–2684. doi:10.1038/emboj.2012.146. PMC   3380217 . PMID   22617420.
  20. ↑ Seeger, C.; Ganem, D.; Varmus, H. (1986). "Biochemical and genetic evidence for the hepatitis B virus replication strategy". Science. 232 (4749): 477–484. Bibcode:1986Sci...232..477S. doi:10.1126/science.3961490. PMID   3961490.
  21. ↑ Jacks, T.; Varmus, H.E. (1985). "Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting". Science. 230 (4731): 1237–42. Bibcode:1985Sci...230.1237J. doi:10.1126/science.2416054. PMID   2416054.
  22. ↑ Bates, P; Young, JA; Varmus, HE (1993). "A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor". Cell. 74 (6): 1043–51. doi:10.1016/0092-8674(93)90726-7. PMID   8402880. S2CID   10787640.
  23. ↑ Pao, W.; Miller, V.; Zakowski, M.; Doherty, J.; Politi, K.; Sarkaria, I.; Singh, B.; Heelan, B.; Rusch, V.; Fulton, L.; Mardis, E.; Kupfer, D; Wilson, R.; Kris, M.; Varmus (2004). "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib". Proceedings of the National Academy of Sciences. 101 (36): 13306–11. doi: 10.1073/pnas.0405220101 . PMC   516528 . PMID   15329413.
  24. ↑ Bishop, J.M.; Kirschner, M.; Varmus, H.E. (1993). "Policy Forum: Science and the New Administration". Science. 259 (5094): 444–445. doi:10.1126/science.8424162. PMID   8424162.
  25. ↑ Varmus, Harold (2009). The Art and Politics of Science. W.W. Norton. pp. 140–196.
  26. ↑ Varmus, Harold (2006). AAAS Bulletin. pp. 6–11, Vol. LIX, No.4.
  27. ↑ Varmus, H. Making PEPFAR: A Triumph of Medical Diplomacy. Science & Diplomacy 2(4) December, 2013.
  28. ↑ Nicholas Thompson: Harold Varmus Endorses Obama, Wired, February 03, 2008
  29. ↑ "Obama Chooses Science Team for Planetary Survival, Prosperity". NBC Southern California. 21 December 2008. Retrieved 2016-03-10.
  30. ↑ "President Obama to Appoint Harold Varmus, M.D., to Lead the National Cancer Institute". nursezone.com. Retrieved 2016-03-10.
  31. ↑ Varmus, H.; Harlow, E. (2012). "Provocative Questions in Cancer Research". Nature. 481 (7382): 436–437. doi: 10.1038/481436a . PMID   22281578. S2CID   205069623.
  32. ↑ "Director's Page". National Cancer Institute. 2015-05-15. Archived from the original on 31 March 2015.
  33. ↑ "The RAS Initiative". National Cancer Institute. December 2014. Retrieved 2016-03-10.
  34. ↑ Reardon, Sara (2015). "Harold Varmus to resign as head of US cancer institute". Nature. doi:10.1038/nature.2015.17063. S2CID   76143569 . Retrieved 2016-03-10.
  35. ↑ "Nobel laureate Harold Varmus to join Weill Cornell April 1". Cornell Chronicle. March 5, 2015. Retrieved 2016-12-28.
  36. ↑ Alberts, B.; Kirschner, M.W.; Tilghman, S.; Varmus, H. (2014). "Rescuing U.S. Biomedical Research from its Systemic Flaws". PNAS. 111 (16): 5773–5777. Bibcode:2014PNAS..111.5773A. doi: 10.1073/pnas.1404402111 . PMC   4000813 . PMID   24733905.
  37. ↑ "Home – Rescuing Biomedical Research". Rescuing Biomedical Research. Retrieved 2016-03-10.
  38. ↑ "Harold Varmus to Step Down as President of Memorial Sloan Kettering Cancer Center". mskcc.org. 12 January 2010.
  39. ↑ "Message from Harold Varmus" (PDF). 12 January 2010.
  40. ↑ "PLOS History". www.plos.org. Retrieved 2016-03-10.
  41. ↑ "Free Radical". WIRED. June 2006. Retrieved 2016-03-10.
  42. ↑ Vastag, Brian (2000-03-01). "NIH Launches PubMed Central". Journal of the National Cancer Institute. 92 (5): 374. doi: 10.1093/jnci/92.5.374 . ISSN   0027-8874. PMID   10699067.
  43. ↑ "Public access to NIH research made law". www.sciencecodex.com. Archived from the original on 2016-03-04. Retrieved 2016-03-10.
  44. ↑ Brown, Patrick O; Eisen, Michael B; Varmus, Harold E (2003). "Why PLoS Became a Publisher". PLOS Biology. 1 (1): E36. doi: 10.1371/journal.pbio.0000036 . PMC   212706 . PMID   14551926.
  45. ↑ Staff (July 2016). "People". Genetic Engineering & Biotechnology News (Paper). Vol. 36, no. 13. p. 37.
  46. ↑ Varmus, H.; Klausner, R.; Zerhouni, E.; Acharya, T.; Daar, A. S.; Singer, P. A. (2003-10-17). "Grand Challenges in Global Health". Science. 302 (5644): 398–399. doi:10.1126/science.1091769. ISSN   0036-8075. PMC   243493 . PMID   14563993.
  47. ↑ "Macroeconomics and health : investing in health for economic development / report of the Commission on Macroeconomics and Health" (PDF).
  48. ↑ "WHO Science Council". who.int. Retrieved 7 October 2023.
  49. ↑ "John Pocock". American Academy of Arts & Sciences. Retrieved 2022-02-22.
  50. ↑ "The Lasker Foundation – 1982 Basic Medical Research Award". Archived from the original on 2015-09-15. Retrieved 2014-10-17.
  51. ↑ "Harold E. Varmus – Nobel Lecture: Retroviruses and Oncogenes I". nobelprize.org.
  52. ↑ "Golden Plate Awardees of the American Academy of Achievement". www.achievement.org. American Academy of Achievement.
  53. ↑ "APS Member History". search.amphilsoc.org. Retrieved 2022-02-22.
  54. ↑ "Professor Harold Varmus ForMemRS". London: Royal Society. Archived from the original on 2015-10-13.
  55. ↑ "Harold E. Varmus 2011 Honoree". Cold Spring Harbor Laboratory. Archived from the original on 2016-12-29. Retrieved 2016-12-28.
  56. ↑ Goldberger, Paul (2008-12-01). "Swing Science". The New Yorker. ISSN   0028-792X . Retrieved 2016-03-10.
Government offices
Preceded by14th Director of the National Institutes of Health
1993 – 1999		Succeeded by
Preceded by14th Director of the National Cancer Institute
2010 – 2015		Succeeded by
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.